SSG
GOVX icon

Summit Securities Group’s GeoVax Labs GOVX Stock Holding History

Summit Securities Group’s Portfolio GOVX Stock Details GOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-120
Closed -$7.41K – 912
2024
Q4 		$7.41K Buy
+120
New +$6.95K ﹤0.01% 490
2022
Q4 		– Sell
-13
Closed -$5K – 1234
2022
Q3 		$5K Hold
13
– – ﹤0.01% 829
2022
Q2 		$4K Buy
+13
New +$5.73K ﹤0.01% 878

Other funds holding GOVX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Summit Securities Group's GOVX Position: Q1 2025 in Review

Summit Securities Group sold out of GeoVax Labs (GOVX) in Q1 2025, closing a stake of 120 shares — an estimated $7.41K sold.

Summit Securities Group first reported a position in GOVX in Q2 2022 and held it in 3 quarters. The position peaked at $7.41K in Q4 2024. 16 funds tracked by Wall St. Rank hold GOVX as of Q1 2025.

  • Summit Securities Group reported no remaining GeoVax Labs position as of Q1 2025 after selling out during the quarter.
  • Summit Securities Group sold 120 GeoVax Labs shares in Q1 2025, an estimated $7.41K.
  • Summit Securities Group first reported a position in GeoVax Labs in Q2 2022 and held it in 3 quarters.
  • Summit Securities Group's GeoVax Labs position peaked at $7.41K in Q4 2024.
  • 16 funds tracked by Wall St. Rank held GeoVax Labs as of Q1 2025.

Based on Summit Securities Group's 13F filing for Q1 2025, filed 13 May 2025.